Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-08-08
1998-07-14
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514294, 514359, 514461, A61K 3144, A61K 3141, A61K 3134
Patent
active
057804818
ABSTRACT:
The invention is a method for inhibiting activation of the human A3 adenosine receptor with adenosine, by treating the receptor a compound of the formula ##STR1## to treat asthma.
REFERENCES:
Salvatore et al., Proc. Natl. Acad. Sci. USA, "Molecular cloning and characterization of the human A3 adenosine receptor", vol. 90, pp. 10365-10369 (1993).
Katritzky et al., Croatica Chemica Acta, "Cycloaddition Reaction Involving Two Heterocyclic Rings. Preparation of Novel Triazolonaphthyridine Ring Systems", vol 59 (1), pp. 27-32 (1986).
Chakravarty Prasun K.
Jacobson Marlene A.
Norton Richard
Criares Theodore J.
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Method for inhibiting activation of the human A3 adenosine recep does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting activation of the human A3 adenosine recep, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting activation of the human A3 adenosine recep will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1882086